Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by Composite Physiologic Index (CPI)

被引：0
|
作者：
Nambiar, A. M. [1 ]
Molina-Molina, M. [2 ]
Padilla, M. [3 ]
Song, J. [4 ]
Mueller, H. [5 ]
Stowasser, S. [5 ]
Rohr, K. B. [5 ]
Wells, A. U. [6 ,7 ]
机构：
[1] Univ Texas Hlth San Antonio, Div Pulm & Crit Care Med, Dept Med, San Antonio, TX USA
[2] Univ Hosp Bellvitge, ILD Unit, IDIBELL, Barcelona, Spain
[3] Icahn Sch Med Mt Sinai, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Pulm & Crit Care Med, Seoul, South Korea
[5] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[6] Royal Brompton & Harefield NHS Fdn Trust, Natl Inst Hlth Res, Resp Biomed Res Unit, London, England
[7] Imperial Coll, Natl Heart & Lung Inst, London, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1905
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Antifibrotics effects of nintedanib on lung fibroblasts derived from patients with progressive fibrosing intertitial lung diseases
    Joannes, Audrey
    Morzadec, Claudie
    Gutierrez, Francisco Llamas
    Chiforeanu, Dan Cristian
    De Latour, Bertrand Richard
    Wollin, Lutz
    Jouneau, Stephane
    Vernhet, Laurent
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [42] Effects of nintedanib in patients with progressive fibrosing ILDs and differing baseline FVC: further analyses of the INBUILD trial
    Valenzuela, Claudia
    Maher, Toby M.
    Bonella, Francesco
    Pesci, Alberto
    Jouneau, Stephane
    Patel, Nina M.
    Perez, Evans R. Fernandez
    Goeldner, Rainer-Georg
    Stowasser, Susanne
    Schlenker-Herceg, Rozsa
    Quaresma, Manuel
    Cottin, Vincent
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [43] Effect of Nintedanib in Patients with Systemic Sclerosis- Associated Interstitial Lung Disease (SSc-ILD) by Composite Physiologic Index (CPI) at Baseline
    Wells, A. U.
    Highland, K. B.
    Glaeser, S.
    Nunes, H.
    Song, J. W.
    Wuyts, W. A.
    Stock, C.
    Alves, M.
    Padilla, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [44] Effects of nintedanib on progression of ILD in patients with fibrosing ILDs and a progressive phenotype: further analyses of the INBUILD trial
    Flaherty, Kevin R.
    Wells, Athol U.
    Cottin, Vincent
    Devaraj, Anand
    Inoue, Yoshikazu
    Richeldi, Luca
    Walsh, Simon L. F.
    Kolb, Martin
    Koschel, Dirk
    Moua, Teng
    Stowasser, Susanne
    Goeldner, Rainer-Georg
    Schlenker-Herceg, Rozsa
    Brown, Kevin K.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [45] Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON
    Bonella, F.
    Wuyts, A. W.
    Chaudhuri, N.
    Varone, F.
    Antin-Ozerkis, D.
    Mueller, H.
    Coeck, C.
    Rohr, B. K.
    Cottin, V
    PNEUMOLOGIE, 2022, 76 : S25 - S26
  • [46] Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON
    Wuyts, Wim A.
    Bonella, Francesco
    Chaudhuri, Nazia
    Varone, Francesco
    Antin-Ozerkis, Danielle
    Mueller, Heiko
    Coeck, Carl
    Rohr, Klaus B.
    Cottin, Vincent
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [47] Continued nintedanib treatment in patients with progressive fibrosing ILDs: interim analysis of INBUILD-ON
    Wuyts, W. A.
    Bonella, F.
    Chaudhuri, N.
    Varone, F.
    Antin-Ozerkis, D.
    Mueller, H.
    Coeck, C.
    Rohr, K. B.
    Cottin, V
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [48] EFFECT OF NINTEDANIB IN PATIENTS WITH PROGRESSIVE FIBROSING ILDS AND PRESERVED LUNG FUNCTION AT BASELINE: FURTHER ANALYSES OF THE INBUILD TRIAL
    Patel, Nina
    Kaner, Robert
    Cerri, Stefania
    Inoue, Yoshikazu
    Mueller, Heiko
    Rohr, Klaus
    Stowasser, Susanne
    Kolb, Martin
    CHEST, 2020, 158 (04) : 1051A - 1052A
  • [49] Progressive fibrosing interstitial lung diseases (PF-ILDs): prevalence and characterization in two Italian referral centers
    Faverio, Paola
    Cassandro, Roberto
    Piluso, Martina
    De Giacomi, Federica
    Della Zoppa, Matteo
    Harari, Sergio Alfonso
    Luppi, Fabrizio
    Pesci, Alberto
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [50] Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial
    Vincent Cottin
    Fernando J. Martinez
    R. Gisli Jenkins
    John A. Belperio
    Hideya Kitamura
    Maria Molina-Molina
    Inga Tschoepe
    Carl Coeck
    Dirk Lievens
    Ulrich Costabel
    Respiratory Research, 23
12345